Zymergen Inc
NASDAQ:ZY
Intrinsic Value
Zymergen, Inc. engages in the design, development, and commercialization of bio-based products. [ Read More ]
There is not enough data to reliably calculate the intrinsic value of ZY.
Fundamental Analysis
Our AI Assistant is coming soon! Stay tuned and thank you for your interest!
Provide an overview
of Zymergen Inc's business.
What risks and challenges
does Zymergen Inc face in the near future?
Summarize the latest earnings report
of Zymergen Inc.
Provide P/E
for Zymergen Inc and its competitors.
Balance Sheet Decomposition
Zymergen Inc
Current Assets | 239.6m |
Cash & Short-Term Investments | 213.6m |
Receivables | 3.7m |
Other Current Assets | 22.4m |
Non-Current Assets | 231.3m |
PP&E | 211.7m |
Intangibles | 7.4m |
Other Non-Current Assets | 12.3m |
Current Liabilities | 52.2m |
Accounts Payable | 12.9m |
Accrued Liabilities | 34.9m |
Other Current Liabilities | 4.4m |
Non-Current Liabilities | 182.1m |
Other Non-Current Liabilities | 182.1m |
Earnings Waterfall
Zymergen Inc
Revenue
|
14.5m
USD
|
Cost of Revenue
|
-48.9m
USD
|
Gross Profit
|
-34.4m
USD
|
Operating Expenses
|
-232.8m
USD
|
Operating Income
|
-267.2m
USD
|
Other Expenses
|
-97.8m
USD
|
Net Income
|
-365m
USD
|
Free Cash Flow Analysis
Zymergen Inc
What is Free Cash Flow?
ZY Profitability Score
Profitability Due Diligence
Zymergen Inc's profitability score is 14/100. The higher the profitability score, the more profitable the company is.
Score
Zymergen Inc's profitability score is 14/100. The higher the profitability score, the more profitable the company is.
ZY Solvency Score
Solvency Due Diligence
Zymergen Inc's solvency score is 45/100. The higher the solvency score, the more solvent the company is.
Score
Zymergen Inc's solvency score is 45/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
ZY Price Targets Summary
Zymergen Inc
Ownership
ZY Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
ZY Price
Zymergen Inc
Average Annual Return |
N/A
|
Standard Deviation of Annual Returns |
N/A
|
Max Drawdown | -98% |
Market Capitalization | 252.3m USD |
Shares Outstanding | 104 355 000 |
Percentage of Shares Shorted | 5.59% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Zymergen, Inc. engages in the design, development, and commercialization of bio-based products. The company is headquartered in Emeryville, California and currently employs 507 full-time employees. The company went IPO on 2021-04-22. Its platform consists of three key capabilities: its collection of accessible biomolecules; its software and data science technology, and its data-driven microbe optimization processes. Its businesses include advanced materials, which seeks to employ bio-advantaged molecules or microbes to develop and deliver products and is focused on four markets: agriculture, water repellency, advanced polymers, and healthcare; drug discovery business leverages its differentiated access to natural products as a source of diverse chemical matter provided by its unified metagenomics database, and automation business, which offers automation technology to organizations involved in lab operations. Its software and data science platform informs, guides, and records its experiments forming the infrastructure for the learning cycle.